R

Remix Therapeutics

Biotech firm developing mRNA-degrading therapies

Director – Companion Diagnostics

Regulatory & Quality (Life Sciences)Posted on Nov 10
Full-timeWatertown, MA, USAIn-person

About the Job

Requirements

  • An advanced degree in a relevant field, such as molecular biology or biomedical engineering, or equivalent experience.
  • At least 10 years of experience in diagnostic development, including at least 4 years leading companion diagnostic (CDx) or in vitro diagnostic (IVD) programs in pharmaceutical, medical device, or diagnostic settings.
  • A proven track record delivering CDx aligned to drug approvals, including successful analytical and clinical validation and device regulatory requirements.
  • Deep understanding of diagnostic platforms, including next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), software, and digital health technologies (DHTs), and their associated verification and validation device standards and quality systems.
  • Experience managing external IVD partners and complex, cross-functional programs.
  • Awareness of evolving regulatory and quality expectations and the ability to translate them into actionable guidance.

Responsibilities

  • Align IVD and clinical milestones, IVD quality and regulatory expectations, and therapeutic timelines.
  • Lead oversight of device and IVD partners, ensuring alignment on scopes of work, timelines, budgets, and quality expectations; manage co-development and governance.
  • Define device and IVD intent, user needs, and target product profiles for CDx platforms, ensuring IVD analytical and clinical performance meets intended use.
  • Partner with biomarker and clinical teams to integrate IVDs into interventional clinical studies, including screening, enrichment, stratification, sample strategy, and operational readiness for device and IVD submissions.
  • Drive analytical validation plans, including accuracy, precision, sensitivity and specificity, limit of detection, and reproducibility, and clinical validation strategies linking assay results to drug safety and efficacy.
  • Support global regulatory strategy and submissions with diagnostic and device partners, including FDA premarket approval (PMA), 510(k), EU In Vitro Diagnostic Regulation (IVDR), and Pharmaceuticals and Medical Devices Agency (PMDA) submissions, pre-submission interactions, and labeling alignment.
  • Ensure compliance with applicable device standards and regulations, including ISO 13485, ISO 14971, Clinical and Laboratory Standards Institute (CLSI) guidelines, Quality Management System Regulation (QMSR), IVDR, and Good Clinical Practice (GCP) alignment for diagnostic and device use in clinical trials.
  • Coordinate cross-functional working groups, conduct audit preparedness for device and IVD Bioresearch Monitoring (BIMO) and pre-approval inspections (PAI), remove program obstacles, and provide transparent status to governance bodies.
  • Oversee document review and coordinate recommended edits from cross-functional teams, IVD partner audit preparedness and manufacturing readiness, and supply planning with diagnostic and device partners to ensure timely clinical and commercial availability.

Desired Qualifications

  • Experience in rare disease and oncology indications.
  • Regulatory Affairs Certification (RAC).

About the Company

Remix Therapeutics

Biotech firm developing mRNA-degrading therapies

Remix Therapeutics develops medicines for rare diseases by using targeted degradation of mRNA with an oral small molecule. Its lead candidate REM 422 degrades messenger RNA to stop production of disease-causing proteins and is in Phase 1 trials for ACC and AML, with FDA Orphan Drug designation. The company funds R&D through grants, partnerships, and eventual commercialization, leveraging collaborations with larger pharma. Its goal is to deliver safe and effective medicines for rare cancers and genetic disorders by advancing REM 422 and expanding its portfolio to address unmet medical needs.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Remix Therapeutics

See more jobs